Suppliers and packagers for PREDNISOLONE

PREDNISOLONE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	23155-927-51	240 mL in 1 BOTTLE (23155-927-51)	2025-03-01
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.	23155-927-52	480 mL in 1 BOTTLE (23155-927-52)	2025-03-01
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Chartwell RX, LLC	62135-250-24	2 TRAY in 1 BOX (62135-250-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-250-45)	2022-11-20
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Chartwell RX, LLC	62135-250-37	240 mL in 1 BOTTLE (62135-250-37)	2022-11-20
Chartwell Rx	PREDNISOLONE	prednisolone	SOLUTION;ORAL	040323	ANDA	Chartwell RX, LLC	62135-250-47	480 mL in 1 BOTTLE (62135-250-47)	2022-11-20

Suppliers for the Pharmaceutical Drug: Prednisolone

Last updated: July 27, 2025

Introduction

Prednisolone, a synthetic corticosteroid, is widely prescribed to manage inflammatory and autoimmune conditions such as asthma, rheumatoid arthritis, and allergic reactions. As a vital medication with significant therapeutic applications, the supply chain for prednisolone involves numerous global manufacturers and suppliers across the pharmaceutical industry. Understanding the landscape of prednisolone suppliers provides insights into market stability, sourcing strategies, and regulatory compliance for stakeholders involved in production, distribution, and procurement.

Global Market Landscape for Prednisolone Suppliers

Major Manufacturers and API Suppliers

Prednisolone is primarily produced via complex chemical synthesis, with active pharmaceutical ingredient (API) manufacturing concentrated among a handful of key players. The leading companies in the API market include:

• Sandoz (Novartis Group): A global leader, Sandoz supplies pre-forms of prednisolone API, leveraging its extensive manufacturing infrastructure. The company is known for adhering to stringent quality standards aligned with both FDA and EMA regulations.
• Mitsubishi Tanabe Pharma Corporation: Based in Japan, Mitsubishi is a significant API manufacturer, catering to various corticosteroids, including prednisolone.
• Shandong Xinhua Pharmaceutical Company: A prominent Chinese API producer, Xinhua Pharmaceuticals has increased its export capacity to meet global demands.
• Fresenius Kabi: While primarily focused on finished dosage forms, they also source APIs from multiple suppliers, including prednisolone, for their generics production.

Contract Manufacturing and Sourcing

Apart from in-house production, pharmaceutical companies often rely on contract manufacturing organizations (CMOs) to produce prednisolone at scale:

• Hetero Labs: An Indian CMO with a significant portfolio of corticosteroid APIs, Hetero works under strict regulatory frameworks to supply prednisolone to global markets.
• Biocon: Also based in India, Biocon specializes in steroid APIs and finished formulations, serving both domestic and international clients.

Regional Supply Dynamics

• Europe: The European pharmaceutical sector sources prednisolone APIs mainly from Sandoz, Teva, and local manufacturers adhering to Good Manufacturing Practices (GMP).
• Asia: India and China are critical sourcing hubs due to lower manufacturing costs and growing capacity, with companies like Hetero, Sipermed, and Shanghai Changyu Chemical contributing significantly.
• North America: The United States predominantly sources APIs from established suppliers or imports finished dosage forms from manufacturers in India and Europe.

Regulatory and Quality Standards

Suppliers operating within the pharmaceutical supply chain must comply with international quality standards like GMP, ISO certifications, and regulatory approvals from agencies like the FDA, EMA, and other national authorities. The integrity of the supply chain hinges on these certifications to prevent contamination, ensure dosage accuracy, and uphold patient safety.

• GMP Compliance: Essential for API producers and finished drug manufacturers. Non-compliance could lead to supply disruptions, legal liabilities, and reputational damage.
• Batch Certification & Traceability: Suppliers are required to provide batch-specific certificates of analysis (CoA), verifying potency, purity, and absence of contaminants.

Supply Chain Challenges and Risk Factors

The prednisolone supply chain faces several risks that could impact availability and pricing:

• Geopolitical Tensions & Trade Policies: Tariffs or export restrictions, especially from China and India, can disrupt API procurement.
• Regulatory Changes: Stringent market entry regulations or withdrawal of GMP certificates can limit supplier capabilities.
• Manufacturing Disruptions: Quality issues, raw material shortages, or factory shutdowns affect supply continuity.
• Demand Fluctuations: Increased COVID-19-related respiratory condition treatments amplified prednisolone demand, stressing supply chains.

Emerging Trends in Prednisolone Supply

Shift Toward Localized Production

To mitigate global supply disruptions, pharmaceutical companies and governments are investing in local API manufacturing facilities in North America and Europe. This shift bolsters supply security but involves high capital expenditure and regulatory hurdles.

Renewed Focus on Quality Assurance

Post-2010s manufacturing scandals prompted stricter oversight. Suppliers now invest heavily in quality assurance, with real-time monitoring and enhanced documentation practices, aligning with regulatory expectations.

Sustainable and Ethical Sourcing

Environmental concerns regarding solvent use and waste disposal are influencing suppliers to adopt greener synthesis methods and sustainable practices, aligning with global environmental standards.

Purchasing and Commercial Considerations

Institutions seeking prednisolone involve selecting suppliers that balance cost, reliability, and regulatory compliance. Due diligence encompasses:

• Verifying GMP certification and quality standards
• Assessing supplier track record and compliance history
• Evaluating logistics capabilities for timely delivery
• Ensuring flexible supply agreements to handle demand spikes

Key Market Players and Suppliers’ Profiles

Company	Location	Specialty	Certifications	Global Reach
Sandoz (Novartis)	Switzerland	API & finished drugs	GMP, ISO	Worldwide
Mitsubishi Tanabe Pharma	Japan	API, corticosteroids	GMP, ISO	Asia, Europe, US
Hetero Labs	India	API, generics	GMP, WHO-GMP, ISO	Global, especially US & Europe
Shandong Xinhua Pharma	China	API, corticosteroids	GMP, ISO	Asia, emerging markets
Teva Pharmaceuticals	Israel	API & small molecules	GMP, ISO	Global

Conclusion

The prednisolone supply chain is characterized by high competitiveness among established API manufacturers, with significant contributions from India, China, Japan, and Europe. Suppliers adhere to rigorous quality and regulatory standards, essential for maintaining global trust. Supply stability depends on navigating geopolitical, regulatory, and manufacturing challenges, with emerging trends favoring localized production and sustainable sourcing. Businesses involved in procurement or manufacturing must prioritize supplier due diligence, regulatory compliance, and risk mitigation strategies to ensure uninterrupted access to this critical medication.

---

Key Takeaways

• The global prednisolone API market is concentrated among reputable suppliers in Europe, North America, India, and China, with leading companies like Sandoz, Mitsubishi, and Hetero.
• Regulatory compliance, especially GMP adherence, remains a pivotal factor influencing supplier selection and market access.
• Supply disruptions are primarily driven by geopolitical issues, manufacturing challenges, and regulatory changes; diversification of suppliers mitigates risks.
• Industry trends focus on localized API manufacturing and sustainable practices, boosting supply security.
• Stakeholders should establish robust due diligence processes, including quality verification and supply chain transparency, to ensure consistent procurement.

---

FAQs

1. Who are the top global suppliers of prednisolone API?
   Leading suppliers include Sandoz (Novartis), Mitsubishi Tanabe Pharma, Hetero Labs, and Shandong Xinhua Pharmaceutical, backed by their GMP certifications and global distribution networks.

2. What factors influence the selection of prednisolone suppliers?
   Key factors include regulatory compliance, product quality, manufacturing capacity, supply reliability, cost efficiency, and sustainability practices.

3. Are there regional differences in prednisolone sourcing?
   Yes. Europe primarily sources from established Western manufacturers; Asia, especially India and China, supply large volumes at competitive prices; North America relies on imports and local manufacturing initiatives.

4. What are typical risks associated with prednisolone supply chains?
   Risks encompass geopolitical trade restrictions, manufacturing disruptions, quality lapses, regulatory shifts, and raw material shortages.

5. How is the prednisolone supply chain evolving amid industry trends?
   The industry is moving toward localized API production, enhanced quality standards, and sustainable manufacturing practices to improve resilience and compliance.

---

Sources:

• [1] Pharmaceutical API Market Analysis, MarketsandMarkets, 2022.
• [2] Global pharmaceutical manufacturing regulations, U.S. FDA guidelines, 2023.
• [3] Industry reports on corticosteroid API producers, ReportLinker, 2022.
• [4] Company websites and annual reports of Sandoz, Mitsubishi Tanabe Pharma, Hetero Labs, and Shandong Xinhua Pharmaceutical.
• [5] Trends in pharmaceutical supply chain resilience, WHO guidelines, 2021.